Paper30770534
A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model.
Han A and 10 others. Clin Infect Dis, 2019. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model. Papers, record 30770534. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30770534
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Influenza A Virus, H3N2 Subtype | Major topic |
| Influenza Vaccines | Major topic |
| Influenza, Human | Major topic |
| Vaccination | Major topic |
| Adolescent | |
| Adult | |
| Antibodies, Viral | |
| Female | |
| Healthy Volunteers | |
| Humans | |
| Immunization Schedule | |
| Male | |
| Middle Aged | |
| Virus Shedding | |
| Young Adult |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| ZIAAI000986 | NIH | NIH RePORTER | |||
| ZIAAI001157 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02594189 | Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers | Derived from the trial | Yes |
Source ClinicalTrials.gov
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 32206777 | Reply to Bernstein, Atmar, and Hoft. | https://conductscience.org/library/papers/32206777 | PubMed |
| Comment in | 32206804 | Influenza Challenge Models: Ready for Prime Time? | https://conductscience.org/library/papers/32206804 | PubMed |
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29506129 | A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases. | J Infect Dis | 2018 | https://conductscience.org/library/papers/29506129 | PubMed |
| 2 | 17942553 | The influenza virus resource at the National Center for Biotechnology Information. | J Virol | 2008 | https://conductscience.org/library/papers/17942553 | PubMed |
| 3 | 30055573 | Using the Influenza Patient-reported Outcome (FLU-PRO) diary to evaluate symptoms of influenza viral infection in a healthy human challenge model. | BMC Infect Dis | 2018 | https://conductscience.org/library/papers/30055573 | PubMed |
| 4 | 16384583 | An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex. | J Mol Biol | 2006 | https://conductscience.org/library/papers/16384583 | PubMed |
| 5 | 3336068 | Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. | J Virol | 1988 | https://conductscience.org/library/papers/3336068 | PubMed |
| 6 | 29477403 | Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients. | Value Health | 2018 | https://conductscience.org/library/papers/29477403 | PubMed |
| 7 | 19427959 | The Bill & Melinda Gates Foundation's grant-making programme for global health. | Lancet | 2009 | https://conductscience.org/library/papers/19427959 | PubMed |
| 8 | 2712549 | Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. | Antiviral Res | 1989 | https://conductscience.org/library/papers/2712549 | PubMed |
| 9 | 24898165 | Influenza activity - United States, 2013-14 season and composition of the 2014-15 influenza vaccines. | MMWR Morb Mortal Wkly Rep | 2014 | https://conductscience.org/library/papers/24898165 | PubMed |
| 10 | 28662019 | Update: Influenza Activity in the United States During the 2016-17 Season and Composition of the 2017-18 Influenza Vaccine. | MMWR Morb Mortal Wkly Rep | 2017 | https://conductscience.org/library/papers/28662019 | PubMed |
| 11 | 25416753 | Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study. | Clin Infect Dis | 2015 | https://conductscience.org/library/papers/25416753 | PubMed |
| 12 | 26042650 | Influenza activity - United States, 2014-15 season and composition of the 2015-16 influenza vaccine. | MMWR Morb Mortal Wkly Rep | 2015 | https://conductscience.org/library/papers/26042650 | PubMed |
| 13 | 20090904 | Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines. | PLoS One | 2010 | https://conductscience.org/library/papers/20090904 | PubMed |
| 14 | 2182673 | Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults. | J Clin Microbiol | 1990 | https://conductscience.org/library/papers/2182673 | PubMed |
| 15 | 7141686 | Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge. | Infect Immun | 1982 | https://conductscience.org/library/papers/7141686 | PubMed |
| 16 | 29045889 | The Pathway to a Universal Influenza Vaccine. | Immunity | 2017 | https://conductscience.org/library/papers/29045889 | PubMed |
| 17 | 3711273 | Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers. | J Clin Microbiol | 1986 | https://conductscience.org/library/papers/3711273 | PubMed |
| 18 | 27281364 | Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine. | MMWR Morb Mortal Wkly Rep | 2016 | https://conductscience.org/library/papers/27281364 | PubMed |
| 19 | 6143042 | Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection. | Lancet | 1984 | https://conductscience.org/library/papers/6143042 | PubMed |
| 20 | 29566007 | Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI). | PLoS One | 2018 | https://conductscience.org/library/papers/29566007 | PubMed |
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972013 | Towards anti-influenza nasal sprays: infection models and opportunities to reduce animal testing. | Npj Viruses | 2026 | https://conductscience.org/library/papers/42972013 | PubMed |
| 42803584 | From viral infection to emission: host barriers shaping airborne transmission. | J Virol | 2026 | https://conductscience.org/library/papers/42803584 | PubMed |
| 42437685 | Hemagglutination Inhibition and Alternate Serologic Responses Following Influenza A(H3N2) Virus Infection. | Influenza Other Respir Viruses | 2026 | https://conductscience.org/library/papers/42437685 | PubMed |
| 42188797 | A Human Mobility-Based Modeling Study of Influenza Vaccination Strategies Across Socioeconomically Disparate Regions in China. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42188797 | PubMed |
| 42089926 | From Trait-Structured Within-Host Dynamics to SIR Models: A Multiscale Framework With Re-Exposure. | Bull Math Biol | 2026 | https://conductscience.org/library/papers/42089926 | PubMed |
| 42078399 | Hemagglutination inhibition and alternate serologic responses following Influenza A(H3N2) virus infection. | medRxiv | 2026 | https://conductscience.org/library/papers/42078399 | PubMed |
| 41282858 | Controlled human influenza infection reveals heterogeneous expulsion of infectious virus into air. | medRxiv | 2025 | https://conductscience.org/library/papers/41282858 | PubMed |
| 40941331 | Dose-Dependent Porcine Deltacoronavirus Infection Reveals Linkage Between Infectious Dose and Immune Response. | Animals (Basel) | 2025 | https://conductscience.org/library/papers/40941331 | PubMed |
| 40748059 | Best Practices in the Development and Use of Experimental Models of Bacterial Pneumonia: An Official American Thoracic Society Workshop Report. | Am J Respir Cell Mol Biol | 2025 | https://conductscience.org/library/papers/40748059 | PubMed |
| 39589151 | Influenza virus infection and aerosol shedding kinetics in a controlled human infection model. | J Virol | 2024 | https://conductscience.org/library/papers/39589151 | PubMed |
| 39471873 | Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4+ decline. | J R Soc Interface | 2024 | https://conductscience.org/library/papers/39471873 | PubMed |
| 39093901 | Single-cell analysis of VACV infection reveals pathogen-driven timing of early and late phases and host-limited dynamics of virus production. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/39093901 | PubMed |
| 39045688 | Symptom propagation in respiratory pathogens of public health concern: a review of the evidence. | J R Soc Interface | 2024 | https://conductscience.org/library/papers/39045688 | PubMed |
| 38701066 | Epidemiological and health economic implications of symptom propagation in respiratory pathogens: A mathematical modelling investigation. | PLoS Comput Biol | 2024 | https://conductscience.org/library/papers/38701066 | PubMed |
| 38063402 | Pan-antiviral effects of a PIKfyve inhibitor on respiratory virus infection in human nasal epithelium and mice. | Antimicrob Agents Chemother | 2024 | https://conductscience.org/library/papers/38063402 | PubMed |
| 37970627 | Propylene glycol inactivates respiratory viruses and prevents airborne transmission. | EMBO Mol Med | 2023 | https://conductscience.org/library/papers/37970627 | PubMed |
| 37732733 | Within-host diversity improves phylogenetic and transmission reconstruction of SARS-CoV-2 outbreaks. | Elife | 2023 | https://conductscience.org/library/papers/37732733 | PubMed |
| 36702771 | A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults. | J Infect Dis | 2023 | https://conductscience.org/library/papers/36702771 | PubMed |
| 36680215 | Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors. | Viruses | 2023 | https://conductscience.org/library/papers/36680215 | PubMed |
| 36190270 | Viral load at hospitalization is an independent predictor of severe COVID-19. | Eur J Clin Invest | 2023 | https://conductscience.org/library/papers/36190270 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30770534
GET https://conductscience.org/api/papers/v1/30770534/references?page=2